150 related articles for article (PubMed ID: 38287819)
1. Parkinson's Disease Diagnosis Using miRNA Biomarkers and Deep Learning.
Kumar A; Kouznetsova VL; Kesari S; Tsigelny IF
Front Biosci (Landmark Ed); 2024 Jan; 29(1):4. PubMed ID: 38287819
[TBL] [Abstract][Full Text] [Related]
2. Alzheimer's Disease Diagnostics Using miRNA Biomarkers and Machine Learning.
Xu A; Kouznetsova VL; Tsigelny IF
J Alzheimers Dis; 2022; 86(2):841-859. PubMed ID: 35147545
[TBL] [Abstract][Full Text] [Related]
3. Involvement of miRNA on epigenetics landscape of Parkinson's disease: From pathogenesis to therapeutics.
Uppala SN; Tryphena KP; Naren P; Srivastava S; Singh SB; Khatri DK
Mech Ageing Dev; 2023 Jul; 213():111826. PubMed ID: 37268278
[TBL] [Abstract][Full Text] [Related]
4. Transcriptomics and Proteomics Approach for the Identification of Altered Blood microRNAs and Plasma Proteins in Parkinson's Disease.
Yadav SK; Jauhari A; Singh N; Pandey A; Sarkar S; Pandey S; Garg RK; Parmar D; Yadav S
Cell Mol Neurobiol; 2023 Oct; 43(7):3527-3553. PubMed ID: 37219663
[TBL] [Abstract][Full Text] [Related]
5. miRNAs and target genes in the blood as biomarkers for the early diagnosis of Parkinson's disease.
Liu X; Chen J; Guan T; Yao H; Zhang W; Guan Z; Wang Y
BMC Syst Biol; 2019 Jan; 13(1):10. PubMed ID: 30665415
[TBL] [Abstract][Full Text] [Related]
6. Serum MicroRNAs Predict Isolated Rapid Eye Movement Sleep Behavior Disorder and Lewy Body Diseases.
Soto M; Iranzo A; Lahoz S; Fernández M; Serradell M; Gaig C; Melón P; Martí MJ; Santamaría J; Camps J; Fernández-Santiago R; Ezquerra M
Mov Disord; 2022 Oct; 37(10):2086-2098. PubMed ID: 35962561
[TBL] [Abstract][Full Text] [Related]
7. Plasma-based circulating MicroRNA biomarkers for Parkinson's disease.
Khoo SK; Petillo D; Kang UJ; Resau JH; Berryhill B; Linder J; Forsgren L; Neuman LA; Tan AC
J Parkinsons Dis; 2012; 2(4):321-31. PubMed ID: 23938262
[TBL] [Abstract][Full Text] [Related]
8. Blood-based gene-expression biomarkers identification for the non-invasive diagnosis of Parkinson's disease using two-layer hybrid feature selection.
Augustine J; Jereesh AS
Gene; 2022 May; 823():146366. PubMed ID: 35202733
[TBL] [Abstract][Full Text] [Related]
9. Several miRNAs derived from serum extracellular vesicles are potential biomarkers for early diagnosis and progression of Parkinson's disease.
He S; Huang L; Shao C; Nie T; Xia L; Cui B; Lu F; Zhu L; Chen B; Yang Q
Transl Neurodegener; 2021 Jul; 10(1):25. PubMed ID: 34315539
[TBL] [Abstract][Full Text] [Related]
10. MicroRNAs in Parkinson's disease: a systematic review and diagnostic accuracy meta-analysis.
Guévremont D; Roy J; Cutfield NJ; Williams JM
Sci Rep; 2023 Sep; 13(1):16272. PubMed ID: 37770507
[TBL] [Abstract][Full Text] [Related]
11. A panel of four decreased serum microRNAs as a novel biomarker for early Parkinson's disease.
Dong H; Wang C; Lu S; Yu C; Huang L; Feng W; Xu H; Chen X; Zen K; Yan Q; Liu W; Zhang C; Zhang CY
Biomarkers; 2016; 21(2):129-37. PubMed ID: 26631297
[TBL] [Abstract][Full Text] [Related]
12. Identification of potential immune-related hub genes in Parkinson's disease based on machine learning and development and validation of a diagnostic classification model.
Xin G; Niu J; Tian Q; Fu Y; Chen L; Yi T; Tian K; Sun X; Wang N; Wang J; Zhang H; Wang L
PLoS One; 2023; 18(12):e0294984. PubMed ID: 38051734
[TBL] [Abstract][Full Text] [Related]
13. Recent developments in circulating biomarkers in Parkinson's disease: the potential use of miRNAs in a clinical setting.
Teixeira Dos Santos MC; Bell R; da Costa AN
Bioanalysis; 2016 Dec; 8(23):2497-2518. PubMed ID: 27855513
[TBL] [Abstract][Full Text] [Related]
14. Emerging urinary alpha-synuclein and miRNA biomarkers in Parkinson's disease.
Giri B; Seamon M; Banerjee A; Chauhan S; Purohit S; Morgan J; Baban B; Wakade C
Metab Brain Dis; 2022 Aug; 37(6):1687-1696. PubMed ID: 33881722
[TBL] [Abstract][Full Text] [Related]
15. A comprehensive bioinformatic analysis revealed novel MicroRNA biomarkers of Parkinson's disease.
Rahimpour A; Heidarzadehpilehrood R; Abdollahi S; Ranjbari H; Shams Z; Ghasemi SA; Najmaei S; Pirhoushiaran M
Cell Biol Int; 2022 Nov; 46(11):1841-1851. PubMed ID: 36098337
[TBL] [Abstract][Full Text] [Related]
16. MicroRNAs, Parkinson's Disease, and Diabetes Mellitus.
Wang H
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33799467
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA expressing profiles in A53T mutant alpha-synuclein transgenic mice and Parkinsonian.
Mo M; Xiao Y; Huang S; Cen L; Chen X; Zhang L; Luo Q; Li S; Yang X; Lin X; Xu P
Oncotarget; 2017 Jan; 8(1):15-28. PubMed ID: 27965467
[TBL] [Abstract][Full Text] [Related]
18. The Potential Regulation of A-to-I RNA Editing on Genes in Parkinson's Disease.
Wu S; Xue Q; Qin X; Wu X; Kim P; Chyr J; Zhou X; Huang L
Genes (Basel); 2023 Apr; 14(4):. PubMed ID: 37107677
[TBL] [Abstract][Full Text] [Related]
19. Down regulation of miR-218, miR-124, and miR-144 relates to Parkinson's disease via activating NF-κB signaling.
Xing RX; Li LG; Liu XW; Tian BX; Cheng Y
Kaohsiung J Med Sci; 2020 Oct; 36(10):786-792. PubMed ID: 32492291
[TBL] [Abstract][Full Text] [Related]
20. Exosomal miRNA as peripheral biomarkers in Parkinson's disease and progressive supranuclear palsy: A pilot study.
Manna I; Quattrone A; De Benedittis S; Vescio B; Iaccino E; Quattrone A
Parkinsonism Relat Disord; 2021 Dec; 93():77-84. PubMed ID: 34839044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
